BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Thursday reported a second-quarter loss of $9.1 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Burlingame, California-based company said it had a loss of 20 cents.

The biopharmaceutical company posted revenue of $3.5 million in the period.

Kindred Bio shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News